Skip to main content
logo
Microba Life Sciences Limited (ASX:MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0530
0.00 (0.00%)
Sep 17, 2026, 9:59 AM AEST

Microba Life Sciences Revenue

In the fiscal year ending June 30, 2026, Microba Life Sciences had annual revenue of 14.76M AUD, down -5.81%. Microba Life Sciences had revenue of 7.44M in the half year ending June 30, 2026, a decrease of -15.64%.

Revenue
14.76M
Revenue Growth
-5.81%
P/S Ratio
2.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.12M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202614.76M-910.63K-5.81%
Jun 30, 202515.67M3.58M29.60%
Jun 30, 202412.09M6.67M123.06%
Jun 30, 20235.42M731.49K15.60%
Jun 30, 20224.69M956.20K25.62%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Healius1.37B
Australian Clinical Labs736.15M
Monash IVF Group269.46M
ImExHS31.27M
Genetic Signatures19.33M
Cryosite16.70M
BCAL Diagnostics2.35M
INOVIQ2.21M
Revenue Rankings

Microba Life Sciences News

More News